{
    "title": "J&J and Merck Ebola vaccines produce lasting antibodies in children and adults -studies",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11539443/J-J-Merck-Ebola-vaccines-produce-lasting-antibodies-children-adults-studies.html",
    "date": "2022-12-14",
    "keywords": [
        "vaccine",
        "dose",
        "health",
        "srinivasan",
        "leo",
        "johnson",
        "merck",
        "strain",
        "ebola",
        "jampjs",
        "booster",
        "study",
        "trial",
        "medicine",
        "center",
        "dec",
        "amp",
        "virusfighting",
        "year",
        "africa",
        "zaire",
        "virus",
        "sudan",
        "outbreak",
        "regimen",
        "shot",
        "drugmaker",
        "nordic",
        "option",
        "placebo",
        "antibody",
        "h",
        "clifford",
        "director",
        "institute",
        "allergy",
        "part",
        "institutes",
        "lane",
        "level",
        "protection",
        "disease",
        "enrollment",
        "place",
        "greenwood",
        "coauthor",
        "school",
        "hygiene",
        "total",
        "collaboration",
        "ministry",
        "university",
        "research",
        "journal",
        "ervebo",
        "regulator",
        "world",
        "organization",
        "jampj",
        "approval",
        "reporting",
        "bengaluru",
        "editing",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}